Related Experiment Video
Updated: Apr 14, 2026
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations
Özgün Babur1, Mithat Gönen2, Bülent Arman Aksoy3,4
1Computational Biology Center, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 460, New York, 10065, USA. mutex@cbio.mskcc.org.
Abstract:
We present a novel method for the identification of sets of mutually exclusive gene alterations in a given set of genomic profiles. We scan the groups of genes with a common downstream effect on the signaling network, using a mutual exclusivity criterion that ensures that each gene in the group significantly contributes to the mutual exclusivity pattern. We test the method on all available TCGA cancer genomics datasets, and detect multiple previously unreported alterations that show significant mutual exclusivity and are likely to be driver events.
Insights
We developed a new method to find mutually exclusive gene alterations in cancer genomics data. This approach identifies potential driver events by analyzing gene groups with common effects on cellular signaling pathways.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Identifying gene alterations is crucial for understanding cancer development.
- Mutual exclusivity among gene alterations can indicate coordinated roles in cancer pathways.
Purpose of the Study:
- To present a novel computational method for identifying sets of mutually exclusive gene alterations.
- To apply this method to The Cancer Genome Atlas (TCGA) datasets to discover new driver events.
Main Methods:
- Scanning gene groups for common downstream effects on signaling networks.
- Utilizing a mutual exclusivity criterion to ensure significant contribution of each gene.
- Testing the method across all available TCGA cancer genomics datasets.
Main Results:
- Detection of multiple previously unreported gene alteration sets.
- Identification of significant mutual exclusivity patterns within these sets.
- These findings suggest potential novel driver events in cancer.
Conclusions:
- The novel method effectively identifies mutually exclusive gene alterations.
- The discovered alterations represent likely driver events, advancing cancer genomics understanding.
- This approach can uncover new therapeutic targets and insights into cancer mechanisms.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...